title: Simple, phage-based (FASTPplaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum.
authors.affiliation: Biotec Laboratories Ltd, c/o National Health Laboratory Service, Cape Town, Western Cape, South Africa. alberth@mweb.co.za
authors.forename: H
authors.initials: H
authors.lastname: Albert
authors.forename: A
authors.initials: A
authors.lastname: Trollip
authors.forename: T
authors.initials: T
authors.lastname: Seaman
authors.forename: R J
authors.initials: RJ
authors.lastname: Mole
mesh_terms: D000904:Antibiotics, Antitubercular / Q000494:pharmacology*; D001331:Automation; D001431:Bacteriological Techniques; D001434:Bacteriophage Typing; D004269:DNA, Bacterial; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000472:pathogenicity*; D015203:Reproducibility of Results; D012293:Rifampin / Q000494:pharmacology*; D012680:Sensitivity and Specificity; D013183:Sputum / Q000382:microbiology
chemical_list: D000904:Antibiotics, Antitubercular; D004269:DNA, Bacterial; D012293:Rifampin